Study Title:
Phase I Study of Nivolumab in Combination with Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma: BTCRC-HEM15-027
- Closed to Accrual at:
- Learn more:
Study Contact: studies@hoosiercancer.org; (317) 921-2050.
Study Title:
Phase I Study of Nivolumab in Combination with Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma: BTCRC-HEM15-027
Study Contact: studies@hoosiercancer.org; (317) 921-2050.
© 2023 All rights reserved.
Big Ten Cancer Research Consortium
7676 Interactive Way, Suite 120, Indianapolis, IN 46278
Subscribe to the Big Ten CRC Newsletter
Twitter
Facebook
YouTube